DiviTum identifies women with high risk of developing breast cancer

Women with mutations in certain genes are predisposed to a high risk of breast cancer (about 50%) up to an age of 70 years. A study published by Dr Benjamin Nisman and colleagues have found that DiviTumTM, Biovicas high-precision test to measure cell growth rate, is important when identifying women with high risk to develop [...]

2013-11-20T11:00:51+01:00 November 20th, 2013 11:00|News|